El Salvador vs Portugal: Pneumococcal conjugate second or third-dose vaccines (PCVc)
El Salvador
98.0%
in 2025
Portugal
98.0%
in 2025
El Salvador rank
11th
Portugal rank
11th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- El Salvador
- Portugal
How they compare
El Salvador currently reports 98.0% against 98.0% in Portugal, a difference of 0.0%.
The two have swapped places 4 times across 18 shared years of data; in 2008 it was Portugal ahead.
El Salvador ranks 11th and Portugal ranks 11th of 194 countries.
Across the 3 decades both report, El Salvador averaged higher in 1 and Portugal in 1.
Head to head by decade
| Decade | El Salvador | Portugal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 91.0% | 36.5% | 54.5% | El Salvador |
| 2020s | 94.7% | 98.0% | 3.3% | Portugal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), El Salvador or Portugal?
- El Salvador, at 98.0% against 98.0% in Portugal as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between El Salvador and Portugal?
- 0.0%, with El Salvador ahead.
- How many years of comparable data are there for El Salvador and Portugal?
- 18 years are reported by both, from 2008 to 2025.
- How do El Salvador and Portugal rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- El Salvador ranks 11th and Portugal ranks 11th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.